TAOP issues 266,666 restricted shares to execs; immediate vesting

Q: How many restricted shares did Taoping (TAOP) grant in July 2025?

The board granted 266,666 ordinary shares on 8 July 2025.

Q: Which Taoping executive received the largest stock award?

CEO & Chairman Jianghuai Lin received 133,332 shares .

Q: Do the granted shares under TAOP's 2024 Equity Incentive Plan have a vesting schedule?

No. All shares vested immediately on the grant date.

Q: Under which filing was Taoping's equity grant disclosed?

It was disclosed in a Form 6-K filed with the SEC.

Q: Will the grant affect Taoping鈥檚 share count?

Yes. The issuance increases the outstanding shares by 266,666 , creating modest dilution.

[Form 4] ACM Research, Inc. Insider Trading Activity

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Taoping Inc. (TAOP) filed a Form 6-K announcing that on 8 July 2025 its board granted a total of 266,666 ordinary shares as restricted-stock compensation under the 2024 Equity Incentive Plan (registered on Form S-8 No. 333-283697). The awards vested immediately, meaning the entire cost will be recognized in the current period and the shares are now free-trading, modestly increasing the company鈥檚 outstanding share count.

Key allocations: CEO & Chairman Jianghuai Lin received 133,332 shares; President Zhiqiang Zhao, COO Zhixiong Huang and CFO Iris Yan each received 36,000; other executives and non-executive directors received between 1,012 and 13,630 shares. No financial performance metrics, cash impact, or other corporate developments were disclosed in this filing.

Positive

None.

Negative

Immediate vesting of 266,666 shares causes instant dilution and offers limited performance or retention alignment for executives.

Insights

TL;DR: Minor dilution from 266k share grant; no earnings data, overall neutral impact.

The grant represents a small percentage of Taoping鈥檚 likely outstanding shares, so economic dilution should be modest. Because all shares vest immediately, GAAP compensation expense will hit the current quarter, slightly depressing near-term earnings. Absent revenue, profit or cash-flow data, the filing has limited valuation impact and is best viewed as routine equity compensation disclosure.

TL;DR: Immediate vesting weakens performance alignment; governance impact modest.

While equity awards are common, best practices favour multi-year vesting to align management with shareholder value creation. Immediate vesting eliminates retention hooks and performance linkage. However, the absolute share count is small and the plan was previously shareholder-approved, so governance risk is contained.

07/09/2025 - 04:30 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Feng Lisa

(Last)

(First)

(Middle)

C/O ACM RESEARCH, INC.

42307 OSGOOD ROAD, SUITE I

(Street)

FREMONT

94539

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
ACM Research, Inc. [ ACMR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	See remarks

3. Date of Earliest Transaction (Month/Day/Year)
07/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	07/07/2025		M⁽¹⁾		15,000	A	$5.6	65,001	D
Class A Common Stock	07/07/2025		S⁽²⁾		15,000	D	$28	50,001	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option	$5.6	07/07/2025		M⁽¹⁾			15,000	⁽³⁾	04/22/2029	Class A Common Stock	15,000	$0	30,000	D

Explanation of Responses:

1. On July 7, 2025, the reporting person exercised a previously issued stock option to purchase 15,000 shares of Class A Common Stock of the Issuer.

2. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2025.

3. The option is fully vested and exercisable.

Remarks:

Chief Financial Officer of ACM Research (Shanghai), Inc., a subsidiary of the Issuer

	/s/ Mark McKechnie, Attorney-in-Fact for Lisa Feng	07/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many restricted shares did Taoping (TAOP) grant in July 2025?

The board granted 266,666 ordinary shares on 8 July 2025.

Which Taoping executive received the largest stock award?

CEO & Chairman Jianghuai Lin received 133,332 shares.

Do the granted shares under TAOP's 2024 Equity Incentive Plan have a vesting schedule?

No. All shares vested immediately on the grant date.

Under which filing was Taoping's equity grant disclosed?

It was disclosed in a Form 6-K filed with the SEC.

Will the grant affect Taoping鈥檚 share count?

Yes. The issuance increases the outstanding shares by 266,666, creating modest dilution.

AG真人官方

[Form 4] ACM Research, Inc. Insider Trading Activity

Insights

FAQ

How many restricted shares did Taoping (TAOP) grant in July 2025?

Which Taoping executive received the largest stock award?

Do the granted shares under TAOP's 2024 Equity Incentive Plan have a vesting schedule?

Under which filing was Taoping's equity grant disclosed?

Will the grant affect Taoping鈥檚 share count?

NASDAQ:ACMR

ACMR Rankings

ACMR Latest News

ACMR Latest SEC Filings

ACMR Stock Data

AG真人官方

Trending News

[Form 4] ACM Research, Inc. Insider Trading Activity

Insights

Financial Analyst neutral

Corporate Governance Expert neutral

FAQ

How many restricted shares did Taoping (TAOP) grant in July 2025?

Which Taoping executive received the largest stock award?

Do the granted shares under TAOP's 2024 Equity Incentive Plan have a vesting schedule?

Under which filing was Taoping's equity grant disclosed?

Will the grant affect Taoping鈥檚 share count?

NASDAQ:ACMR

ACMR Rankings

ACMR Latest News

ACMR Latest SEC Filings

ACMR Stock Data